A prospective multicenter phase II study on the efficacy and safety of dasatinib in the treatment of metastatic gastrointestinal stromal tumors failed by imatinib and sunitinib and analysis of NGS in peripheral blood.
Cancer Medicine
Zhou, Ye Y; Zhang, Xinhua X; Wu, Xiaojun X; Zhou, Yongjian Y; Zhang, Bo B; Liu, Xiufeng X; Wu, Xin X; Li, Yan Y; Shen, Lin L; Li, Jian J